ASCO® 2024 Insights: Dr. Daniel Petrylak

ASCO® 2024 Insights: Dr. Daniel Petrylak on ARV-766Подробнее

ASCO 2024: How to Best Use New Breast Cancer DataПодробнее

ASCO 2024: What's New in Breast Cancer Research?Подробнее

Yale Advancements in Oncology: Implementing the Best Science from ASCO® 2024 and BeyondПодробнее

ASCO GU 2020: Dr. Petrylak Discusses Exciting Prostate Cancer and Bladder Cancer DataПодробнее

ASCO 2024: Dr. Jhannelle Gray Discusses Lung CancerПодробнее

ASCO 2024: Advances in Targeted Therapy for Lung CancerПодробнее

Dr. Dan Petrylak Discusses Prostate and Bladder Cancer at ASCO 2014Подробнее

Best of ASCO 2024: What Patients Need to KnowПодробнее

ASCO 2024: What the ESOPEC, RENAISSANCE, and ARMANI Trials Mean for the Future of Esophageal Canc...Подробнее

ASCO 2024 annual conference highlightsПодробнее

Daniel P. Petrylak, MD, offers opinion on the POUT study presented at ASCO GU 2018Подробнее